H1N1 vaccine2

Seasonal influenza vaccine2

Age group

Male

Female

Overall

Doses
Administered3
 (million)

Rate4

Male

Female

Overall

Doses administered3
(million)

Rate4

No.

%

No.

%

No.

%

No.

%

No.

%

No.

%

<17

7

35.0

10

22.2

17

26.2

19.0

0.89

9

40.9

7

19.4

16

27.6

26.3

0.61

18-49

8

40.0

28

62.2

36

55.3

13.5

2.67*

8

36.4

22

61.1

30

51.7

31.9

0.94

50-64

5

25.0

7

15.6

12

18.5

6.2

1.94*

5

22.7

6

16.7

11

19.0

21.3

0.52

>65

0

0

0

0

0

0

4.7

0

0

0

1

2.8

1

1.7

22.7

0.04

Total

20

100.0

45

100.0

65

100.0

43.4

1.50*

22

100.0

36

100.0

58

100.0

102.2

0.57

1Reports to VAERS received from July 1, 2009 through January 31, 2010 and vaccinated by November 30, 2009
2Simultaneous administration of seasonal influenza and 2009-H1N1 vaccines were included
3Based on data from the National 2009 H1N1 Flu Survey and 2010 U. S. Census
4Per million vaccine doses administered
*Significant difference (p<0.05) in reporting rates when compared to seasonal influenza vaccine
Table 3: Age and gender distribution and reporting rates by age group of verified Bellís palsy cases following 2009-H1N1 and 2009-2010 seasonal influenza vaccines1.